Interstitial pneumonitis following autologous bone marrow transplantation.
The incidence of interstitial pneumonitis (IP) was reviewed in 70 consecutive patients who received autologous marrow transplants for hematologic malignancies. All patients were treated with total-body irradiation (TBI), with or without other chemotherapeutic agents. Seven patients (10%) developed IP, 3 were due to cytomegalovirus, 1 due to Pneumomcystis carinii, and 3 of unknown cause (idiopathic). Risk factors for developing IP were increasing age and a prior history of irradiation to the chest. The use of methotrexate posttransplant did not increase the incidence of IP.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000914:Antibodies, Viral / Q000032:analysis; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003586:Cytomegalovirus Infections / Q000209:etiology; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D011183:Postoperative Complications; D011658:Pulmonary Fibrosis / Q000209:etiology*; D014182:Transplantation, Autologous; D014916:Whole-Body Irradiation
D000914:Antibodies, Viral; D008727:Methotrexate